Exploring Nasal Drop Therapy With Small Extracellular Vesicles for ALS

NCT06598202 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

38

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: exosomes derived from human umbilical cord blood mesenchymal stem cells for nasal drop
DRUG: a placebo of exosomes derived from human umbilical cord blood mesenchymal stem cells for nasal drop

Sponsor

Xuanwu Hospital, Beijing

Collaborators

[object Object]
[object Object]